$86.03
3.023.64%
Last update: Nov 6, 5:27 PM
Dianthus Therapeutics Inc
DNTHNASDAQ
Dianthus Therapeutics (DNTH) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.96 | $-0.91 | $-1.12 | $-1.01 |
| Actual | $-0.81 | $-0.90 | $-0.85 | $-1.43 |
| Surprise | +15.6% | +1.10% | +24.1% | -41.6% |
| Revenue | ||||
| Estimate | $450928 | $293000 | $396952 | $476950 |
| Actual | $1.2M | $761000 | $463000 | $284000 |
| Surprise | +168.3% | +159.7% | +16.6% | -40.5% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.10 | $-1.09 | $-1.14 | $-1.20 |
| Revenue | ||||
| Consensus | $371288 | $513328 | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $-0.81 | $-0.96 | 15.6 % |
| Q2 | Aug 4, 2026 | $-0.90 | $-0.91 | 1.10 % |
| Q1 | May 5, 2026 | $-0.85 | $-1.12 | 24.1 % |
| Q4 | Mar 9, 2026 | $-1.43 | $-1.01 | -41.6 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $1.21M | $450.93K | 168.3 % |
| Q2 | Aug 4, 2026 | $761.00K | $293.00K | 159.7 % |
| Q1 | May 5, 2026 | $463.00K | $396.95K | 16.6 % |
| Q4 | Mar 9, 2026 | $284.00K | $476.95K | -40.5 % |
